Abstract:The human microbiome plays an important role in human health, from metabolism to immunity. In the last few decades, advances in synthetic biology have enabled scientists to design and engineer live microorganisms for therapeutic purposes. In this review, we outline major strategies for manipulating the microbiome, which include three emerging areas with promising therapeutic applications: engineered commensal bacteria, synthetic microbial consortia and targeted modulation by phages. Furthermore, we highlight the applications of engineered live biotherapeutics in treating a variety of human diseases, including pathogenic infections, metabolic disorders, inflammatory bowel disease and colorectal cancer. Finally, we provide an overview of the challenges and opportunities in the future development of engineered live biotherapeutics.This article is protected by copyright. All rights reserved

Engineered Live Biotherapeutics: Progress and Challenges